Osilodrostat
Back to searchMolecule Structure
Scientific Name
Osilodrostat
Description of the Drug
Osilodrostat is an oral inhibitor of cortisol synthesis used to treat Cushing’s disease by normalizing hypercortisolism.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11837
http://www.drugbank.ca/drugs/DB11837
Brand Name(s)
Not Available
Company Owner(s)
Recordati Rare Diseases Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cytochrome P450 11B1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1908 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL12460772 | |
DrugBank | DB11837 | |
PubChem: Thomson Pharma | 85095657 | |
PubChem | 44139752 | |
PDBe | YSY | |
BindingDB | 50444549 | |
EPA CompTox Dashboard | DTXSID40156570 | |
DrugCentral | 5384 | |
ChemicalBook | CB32628027 | |
Guide to Pharmacology | 8310 | |
rxnorm | OSILODROSTAT PHOSPHATE | OSILODROSTAT |
ZINC | ZINC000072318114 |